AFFYMETRIX (AFFX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
AFFYMETRIX (AFFX)

An SI Board Since April 1996

Posts	SubjectMarks	Bans	Symbol
1728	86	0	AFFX

Emcee: Jed Davidow	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
303	The company appears to have real potential, and it's easy to get bullish ov	JF Quinnelly	-	4/20/1997
302	Hi to everyone. I am curious as to what the sentiment is on this thread about	David Rangel	-	4/20/1997
301	Jed, I have a few questions regarding the 'p53' genechip under develop	Michael McVey Lusk	-	4/18/1997
300	Please comment on the benefits and drawbacks of sequencing using the gene chip	Troll_29	-	4/18/1997
299	Affymetrix, Inc. First Quarter Results of -0.22, 7:00am. biz.yahoo.com Philip	Philip H. Lee	-	4/18/1997
298	I have been working at AFFX since January as a research assistant... I will be	Jed Davidow	-	4/18/1997
297	Van Kasper analyst David Pryce initiated AFFX with "Long-Term Buy" an	Philip H. Lee	-	4/18/1997
296	Hey cytokine 1, check out the INCY site later. Dave and I are going to post ou	Vector1	-	4/9/1997
295	V1, found not just one, but three genechip articles at NY Times site...........	Cytokine1	-	4/9/1997
294	Thanks for the link Martin. Good article. Dave	Rocketman	-	4/9/1997
293	As previouly mentioned on the thread the NY Times Science section had an excell	Vector1	-	4/9/1997
292	Thanks, Ace--Here's the Fortune AFFX "Breakthru" link--Hi Dave &a	Cytokine1	-	4/9/1997
291	NICE article on AFFX in todays New York Times Science section! You can check i	Jay Brandes	-	4/8/1997
290	FORTUNE Magazine 3/31 , Page 56 "Gene Chip Breakthrough" New chips t	Ace	-	4/7/1997
289	Sure beats the one drug company in endless clinical trials that statistically w	Rocketman	-	4/5/1997
288	None of the risks you identify, in so far as they are valid, are unique to AFFX	William Marsh	-	4/4/1997
287	AFFX should report earnings on 4/17/97, according to Zacks. End. Philip	Philip H. Lee	-	4/4/1997
286	I understand you concerns about the risks. But if you ask anyone who has ever	Frances Liu	-	4/4/1997
285	Philip, I have to agree with the others - there is nothing in the 10k that was	Michael McVey Lusk	-	4/4/1997
284	Same price range machines as PE:ABI 377 sequencers, 135K or so. They are also	Rocketman	-	4/3/1997
283	AFFX 10K comments. The fact that 10K's are usually very cautious isn't	Philip H. Lee	-	4/3/1997
282	Looks like a typical 10-K to me. If they don't make you wonder why the comp	JF Quinnelly	-	4/3/1997
281	Those warnings and cautions have been in all the reports filed by AFFX in Edgar	William Marsh	-	4/3/1997
280	Finished selling most of my AFFX at the close. I sold about 90% of my AFFX tod	Philip H. Lee	-	4/3/1997
279	Sold 1/2 of my AFFX this morning. I plan to clear out most of my remaining pos	Philip H. Lee	-	4/3/1997

Go to reply# or date (mm/dd/yy):